 |
L-pyr-L-glu-L-gln-L-leu-L-glu-L-arg-L-ala-L-leu-L-asn-L-ser-L-ser |
|---|---|
| Trade Name | |
| Orphan Indication | Treatment to increase survival and improve functioning of pancreatic islets following transplantation |
| USA Market Approval | USA |
| USA Designation Date | 2016-06-13 00:00:00 |
| Sponsor | Araim Pharmaceuticals, Inc.;580 White Plains Road, Suite 210;Tarrytown, New York, 10591 |
